93 related articles for article (PubMed ID: 19628077)
1. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.
Flowers A; Chu QD; Panu L; Meschonat C; Caldito G; Lowery-Nordberg M; Li BD
Surgery; 2009 Aug; 146(2):220-6. PubMed ID: 19628077
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer.
Pinto-Díez C; García-Recio EM; Pérez-Morgado MI; García-Hernández M; Sanz-Criado L; Sacristán S; Toledo-Lobo MV; Pérez-Mies B; Esteban-Rodríguez I; Pascual A; Garcia-Villanueva M; Martínez-Jañez N; González VM; Martín ME
Oncotarget; 2018 Mar; 9(17):13501-13516. PubMed ID: 29568373
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer patient-derived microtumors resemble tumor heterogeneity and enable protein-based stratification and functional validation of individualized drug treatment.
Anderle N; Schäfer-Ruoff F; Staebler A; Kersten N; Koch A; Önder C; Keller AL; Liebscher S; Hartkopf A; Hahn M; Templin M; Brucker SY; Schenke-Layland K; Schmees C
J Exp Clin Cancer Res; 2023 Aug; 42(1):210. PubMed ID: 37596623
[TBL] [Abstract][Full Text] [Related]
4. Depletion of
Thakur C; Carruthers NJ; Zhang Q; Xu L; Fu Y; Bi Z; Qiu Y; Zhang W; Wadgaonkar P; Almutairy B; Guo C; Stemmer PM; Chen F
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009568
[TBL] [Abstract][Full Text] [Related]
5. The Novel Mnk1/2 Degrader and Apoptosis Inducer VNLG-152 Potently Inhibits TNBC Tumor Growth and Metastasis.
Ramalingam S; Ramamurthy VP; Gediya LK; Murigi FN; Purushottamachar P; Huang W; Choi EY; Zhang Y; Vasaitis TS; Kane MA; Lapidus RG; Njar VCO
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30832411
[TBL] [Abstract][Full Text] [Related]
6. A novel function of cIAP1 as a mediator of CHIP-driven eIF4E regulation.
Seo TW; Lee JS; Choi YN; Jeong DH; Lee SK; Yoo SJ
Sci Rep; 2017 Aug; 7(1):9816. PubMed ID: 28852129
[TBL] [Abstract][Full Text] [Related]
7. Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development.
Vaklavas C; Blume SW; Grizzle WE
Front Oncol; 2017; 7():158. PubMed ID: 28798901
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting the MNK-eIF4E-β-catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapy.
Li Z; Sun Y; Qu M; Wan H; Cai F; Zhang P
Oncotarget; 2017 Jan; 8(2):2906-2915. PubMed ID: 27926520
[TBL] [Abstract][Full Text] [Related]
9. Targeted Dual pH-Sensitive Lipid ECO/siRNA Self-Assembly Nanoparticles Facilitate In Vivo Cytosolic sieIF4E Delivery and Overcome Paclitaxel Resistance in Breast Cancer Therapy.
Gujrati M; Vaidya AM; Mack M; Snyder D; Malamas A; Lu ZR
Adv Healthc Mater; 2016 Nov; 5(22):2882-2895. PubMed ID: 27723260
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of eIF4E in colorectal cancer patients is associated with liver metastasis.
Xu T; Zong Y; Peng L; Kong S; Zhou M; Zou J; Liu J; Miao R; Sun X; Li L
Onco Targets Ther; 2016; 9():815-22. PubMed ID: 26929650
[TBL] [Abstract][Full Text] [Related]
11. Targeting translation initiation in breast cancer.
Akcakanat A; Hong DS; Meric-Bernstam F
Translation (Austin); 2014; 2(1):e28968. PubMed ID: 26779407
[TBL] [Abstract][Full Text] [Related]
12. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
13. The ShcA adaptor activates AKT signaling to potentiate breast tumor angiogenesis by stimulating VEGF mRNA translation in a 4E-BP-dependent manner.
Im YK; La Selva R; Gandin V; Ha JR; Sabourin V; Sonenberg N; Pawson T; Topisirovic I; Ursini-Siegel J
Oncogene; 2015 Mar; 34(13):1729-35. PubMed ID: 24837366
[TBL] [Abstract][Full Text] [Related]
14. First MNKs degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines.
Ramalingam S; Gediya L; Kwegyir-Afful AK; Ramamurthy VP; Purushottamachar P; Mbatia H; Njar VC
Oncotarget; 2014 Jan; 5(2):530-43. PubMed ID: 24504069
[TBL] [Abstract][Full Text] [Related]
15. EIF4E over-expresses and enhances cell proliferation and cell cycle progression in nasopharyngeal carcinoma.
Wu M; Liu Y; Di X; Kang H; Zeng H; Zhao Y; Cai K; Pang T; Wang S; Yao Y; Hu X
Med Oncol; 2013 Mar; 30(1):400. PubMed ID: 23277284
[TBL] [Abstract][Full Text] [Related]
16. Detection of eukaryotic translation initiation factor 4E and its clinical significance in hepatocellular carcinoma.
Wang XL; Cai HP; Ge JH; Su XF
World J Gastroenterol; 2012 May; 18(20):2540-4. PubMed ID: 22654452
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic AKTivation of translation as a therapeutic target.
Hsieh AC; Truitt ML; Ruggero D
Br J Cancer; 2011 Jul; 105(3):329-36. PubMed ID: 21772331
[TBL] [Abstract][Full Text] [Related]
18. Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer.
Hsieh AC; Ruggero D
Clin Cancer Res; 2010 Oct; 16(20):4914-20. PubMed ID: 20702611
[TBL] [Abstract][Full Text] [Related]
19. The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival.
Wheater MJ; Johnson PW; Blaydes JP
Cancer Biol Ther; 2010 Oct; 10(7):728-35. PubMed ID: 20686366
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
